Page last updated: 2024-08-24

esmolol and etomidate

esmolol has been researched along with etomidate in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Begec, Z; But, A; Demirbilek, S; Erdil, F; Ozcan Ersoy, M; Ozturk, E	1
McGrath, M; Raines, DE	1

Reviews

1 review(s) available for esmolol and etomidate

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for esmolol and etomidate

Article	Year
The effect of esmolol on the QTc interval during induction of anaesthesia in patients with coronary artery disease. Anaesthesia, 2009, Volume: 64, Issue:3 Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Blood Pressure; Coronary Artery Bypass; Coronary Artery Disease; Electrocardiography; Etomidate; Female; Fentanyl; Heart Rate; Humans; Intubation, Intratracheal; Male; Middle Aged; Propanolamines; Prospective Studies	2009

Article

Year

The effect of esmolol on the QTc interval during induction of anaesthesia in patients with coronary artery disease.

Anaesthesia, 2009, Volume: 64, Issue:3

Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Blood Pressure; Coronary Artery Bypass; Coronary Artery Disease; Electrocardiography; Etomidate; Female; Fentanyl; Heart Rate; Humans; Intubation, Intratracheal; Male; Middle Aged; Propanolamines; Prospective Studies

2009

Other Studies

4 other study(ies) available for esmolol and etomidate

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Anesthetic Drug Discovery and Development: A Case Study of Novel Etomidate Analogs. Methods in enzymology, 2018, Volume: 603 Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Anesthetics, Intravenous; Animals; Binding Sites; Biotransformation; Drug Discovery; Etomidate; Hypnosis, Anesthetic; Hypnotics and Sedatives; Larva; Molecular Docking Simulation; Propanolamines; Protein Binding; Rana pipiens; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Reflex, Righting; Remifentanil; Steroid 11-beta-Hydroxylase; Structure-Activity Relationship	2018